Drug Shortage Report for APO-AMOXI

Last updated on 2024-02-14 History
Report ID 166621
Drug Identification Number 00628131
Brand name APO-AMOXI
Common or Proper name AMOXICILLIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN
Strength(s) 125MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100 mL and 150 mL
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-09
Estimated end date 2023-10-13
Actual end date 2023-10-05
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-02-02 English Compare
v15 2023-01-20 French Compare
v14 2023-01-20 English Compare
v13 2023-01-13 French Compare
v12 2023-01-13 English Compare
v11 2022-12-23 French Compare
v10 2022-12-23 English Compare
v9 2022-11-18 English Compare
v8 2022-11-18 English Compare
v7 2022-11-18 English Compare
v6 2022-11-08 French Compare
v5 2022-11-08 English Compare
v4 2022-11-04 French Compare
v3 2022-11-04 English Compare
v2 2022-08-12 French Compare
v1 2022-08-12 English Compare

Showing 21 to 36 of 36